Literature DB >> 28703392

A comparison between vitamin K antagonists and new oral anticoagulants.

Oscar M P Jolobe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28703392      PMCID: PMC5651312          DOI: 10.1111/bcp.13347

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Carotid artery stenosis in ischemic stroke patients with nonvalvular atrial fibrillation.

Authors:  Yeu-Jhy Chang; Shan-Jin Ryu; Shinn-Kuang Lin
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

Review 2.  Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.

Authors:  John Eikelboom; Geno Merli
Journal:  Am J Med       Date:  2016-08-30       Impact factor: 4.965

3.  Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab.

Authors:  Tim Bastian Braemswig; Christoph C Eschenfelder; Christian H Nolte
Journal:  Am J Emerg Med       Date:  2016-10-29       Impact factor: 2.469

4.  Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.

Authors:  Emilie M Gieling; Hendrika A van den Ham; Hein van Onzenoort; Jacqueline Bos; Cornelis Kramers; Anthonius de Boer; Frank de Vries; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2017-03-24       Impact factor: 4.335

Review 5.  Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.

Authors:  Ida Ehlers Albertsen; Lars Hvilsted Rasmussen; Thure Filskov Overvad; Tina Graungaard; Torben Bjerregaard Larsen; Gregory Y H Lip
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

6.  Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction.

Authors:  Richard I Lindley; Joanna M Wardlaw; Peter A G Sandercock; Prapan Rimdusid; Stephanie C Lewis; David F Signorini; Stefano Ricci
Journal:  J Stroke Cerebrovasc Dis       Date:  2004 Nov-Dec       Impact factor: 2.136

7.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971

Review 8.  Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention.

Authors:  Jeffrey Steven Habert
Journal:  Int J Gen Med       Date:  2016-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.